Literature DB >> 2687694

The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.

R T Sawyer1, A G Harmsen.   

Abstract

Cortisone (CA) or cyclophosphamide (Cy) treatment of mice was used to investigate the relative contributions of pulmonary alveolar macrophages (PAM) and inflammatory neutrophils (PMN) in the initial defense against intratracheal challenge (IT) with Candida albicans. Mice treated with either CA or Cy were susceptible to IT challenge with 10-100 x less C. albicans than were untreated mice. Untreated mice rapidly eliminated C. albicans from their lungs with the majority of the organisms being cleared within three hours of challenge. Mice treated with CA initially cleared some of the C. albicans but were unable to clear all the C. albicans as did the untreated mice. Mice treated with Cy were unable to clear C. albicans from their lungs. Candida albicans did not disseminate from the lungs of untreated mice, while in both of the treated groups, C. albicans disseminated to the liver, spleen, brain and kidneys, rapidly killing the treated hosts. Analysis of the changes in cells in lung lavage fluids collected at various times after C. albicans challenge, revealed that large numbers of PMN accumulated in the lungs of both untreated and CA-treated mice, whereas PMN were virtually undetectable in lavage fluids from Cy-treated mice. Resident PAM from untreated mice were able to kill approximately 70% of 10(5) C. albicans in a 3 hr in vitro killing assay. By contrast, at similar effector:target ratios, resident PAM from Cy-treated mice killed only about 20% of the inoculum and resident PAM from CA-treated mice were unable to kill C. albicans. PMNs from both untreated and CA-treated mice killed approximately 70% of 10(5) C. albicans in vitro. The data indicates that both PAM and PMN were critical to the initial clearance of C. albicans from pulmonary tissue. The accumulation of PMN in the lungs appeared to be required for the complete clearance of C. albicans from the lungs yet was not sufficient to inhibit dissemination of C. albicans from the lungs in CA-treated mice. The presence of PAM with in vitro candidacidal abilities appeared to be required for both the clearance of C. albicans and inhibition of dissemination of C. albicans from the lungs. Compromise of either PAM or PMN function can lead to increased pulmonary susceptibility to C. albicans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687694     DOI: 10.1007/bf00436059

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  25 in total

1.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

Review 2.  Pulmonary clearance of infectious agents.

Authors:  G M Green
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

Review 3.  Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation.

Authors:  A Schaffner; T Schaffner
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

4.  Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating-factor production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair.

Authors:  S M Wahl; L M Wahl
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

5.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

6.  Rapid killing of monocytes in vitro by Candida albicans yeast cells.

Authors:  D L Danley; J Polakoff
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.

Authors:  M Baccarini; F Bistoni; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Effects of cyclophosphamide on murine candidiasis.

Authors:  S A Moser; J E Domer
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

10.  Inhibition of macrophage tumoricidal activity by glucocorticoids.

Authors:  M M Hogan; S N Vogel
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

View more
  9 in total

Review 1.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

2.  Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.

Authors:  K Hata; J Kimura; H Miki; T Toyosawa; M Moriyama; K Katsu
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver.

Authors:  R T Sawyer; R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Intravenous zymosan-A challenge induces an alveolar inflammatory response.

Authors:  R T Sawyer
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

5.  Cytosolic phospholipase a2 activation by Candida albicans in alveolar macrophages: role of dectin-1.

Authors:  Rajinder P Parti; Robyn Loper; Gordon D Brown; Siamon Gordon; Philip R Taylor; Joseph V Bonventre; Robert C Murphy; David L Williams; Christina C Leslie
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-05       Impact factor: 6.914

Review 6.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

7.  Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.

Authors:  Martinna Bertolini; Amit Ranjan; Angela Thompson; Patricia I Diaz; Takanori Sobue; Kendra Maas; Anna Dongari-Bagtzoglou
Journal:  PLoS Pathog       Date:  2019-04-22       Impact factor: 7.464

8.  Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection.

Authors:  Sabarirajan Jayaraja; Azzeddine Dakhama; Bogeon Yun; Moumita Ghosh; HeeJung Lee; Elizabeth F Redente; Charis L Uhlson; Robert C Murphy; Christina C Leslie
Journal:  BMC Immunol       Date:  2016-08-08       Impact factor: 3.615

9.  The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis.

Authors:  Martinna Bertolini; Anna Dongari-Bagtzoglou
Journal:  J Fungi (Basel)       Date:  2019-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.